World Journal of
Pharmaceutical and Life Sciences

( An ISO 9001:2015 Certified International Journal )

An International Peer Reviewed Journal for Pharmaceutical and Life Sciences
An Official Publication of Society for Advance Healthcare Research (Reg. No. : 01/01/01/31674/16)
World Journal of Pharmaceutical and Life Sciences (WJPLS) has indexed with various reputed international bodies like : Google Scholar, Index Copernicus, Indian Science Publications, SOCOLAR, China, Cosmos Impact Factor, Research Bible, Fuchu, Tokyo. JAPAN, Scientific Indexing Services (SIS), Jour Informatics (Under Process), UDLedge Science Citation Index, Global Impact Factor (In Process), International Impact Factor Services, International Scientific Indexing, UAE, International Society for Research Activity (ISRA) Journal Impact Factor (JIF), Science Library Index, Dubai, United Arab Emirates, International Innovative Journal Impact Factor (IIJIF), Scientific Journal Impact Factor (SJIF), Eurasian Scientific Journal Index (ESJI), Indian citation Index (ICI), IFSIJ Measure of Journal Quality, International Scientific Indexing, UAE (ISI), Web of Science Group (Under Process), Directory of Research Journals Indexing, Scholar Article Journal Index (SAJI), International Scientific Indexing ( ISI ), Scope Database, 



Sayyada Kazim, Samra Kazim, Sabiha Kazim, Rais A Ansari, Wilfredo Hernandez, Leon Ferder and Dr. Kazim Husain*


This study evaluated the anticancer activity of ?-tocotrienol (DT3), a bioactive form of vitamin E, in the inhibition of gastric cancer growth and survival compared with other three forms ?-, ?- and ?-tocotrienol (AT3, BT3 and GT3). DT3 is the most bioactive form of vitamin E in inhibiting the cell proliferation of non-metastatic (AGS) and metastatic (746T) gastric cancer cells followed by GT3 and BT3. However, AT3 is devoid of any inhibitory effect on gastric cancer cell viability. The estimated IC50 values are 80+5, 55+5 and 40+5 ?M for BT3, GT3 and DT3, respectively in both cell lines. DT3 (40 ?M) significantly inhibited malignant transformation (p <0.02, p <0.01), cell migration (p <0.01) and invasion (p < 0.05, p < 0.02) compared to vehicle in AGS and 746T cells. DT3 inhibited markers for epithelial (E-cadherin) to mesenchymal (vimentin) transition (EMT), metastasis (matrix metalloproteinase 9 [MMP9]), angiogenesis (Vascular endothelial growth factor [VEGF]), inflammation (Nuclear factor-kappa B [NF-kB]), and Wnt signaling (?-catenin) and its downstream transcriptional targets C-MYC, Cyclin D1 and survivin compared to vehicle. In addition DT3 also induced apoptosis in gastric cancer cells (AGS and 746T). Taken together, these data demonstrate that DT3 is a potential therapeutic agent in advanced gastric cancer and warrants further investigation for its clinical use in the prevention and treatment of gastric cancer.

[Full Text Article]


World Journal of Pharmaceutical and life sciences Will give best paper award in every issue in the from of money along with certificate to promote research .

Best Article of current issue

Download Article : Click here